Literature DB >> 3036739

Characterization of a murine tumor of spontaneous origin with selective hepatic metastasis.

C B Jones, M H Goldrosen.   

Abstract

The primary objective of this study was to establish the identity and characteristics of a murine uterine tumor of spontaneous origin in a C57Bl/6 Ros mouse that selectively metastasized to the liver. The primary tumor contained a minimum of two different cell types. One cell type was elongated and spindly and readily adhered to a plastic coated surface. From it, a permanent cell line, termed RCS-1 was established. The RCS-1 cell line was poorly tumorigenic in normal C57Bl/6 Ros mice. The other cell type, designated RCS-2, was more rounded in structure. It was maintained in vivo, enzymatically dissociated and used after short-term in vitro cell culture. The RCS-2 cells had phagocytic vacuoles, Fc, and C3 receptors. These cells phagocytosed antibody coated SRBCs and opsonized zymosan. Furthermore, these cells generated the superoxide anion. Thus, the RCS-2 cells are of macrophage origin. The spontaneous and experimental pattern of metastasis of the RCS-2 tumor cells was established. The RCS-2 tumor cells selectively metastasized to the liver by the hematogenous route. Metastatic RCS-2 tumor cells obtained from the liver (RCS-2M) retained their macrophage characteristics. These studies indicate that this murine uterine tumor of spontaneous origin consists of two cell types. One cell type is a reticulum cell sarcoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036739

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  2 in total

1.  Mechanism of liver-specific metastatic tumor spread in a murine tumor model.

Authors:  G Edel
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

2.  Organ-specific growth of a murine lymphoma of spontaneous origin in nude mice.

Authors:  A Tomasoni; E Scanziani; G Massazza; G Giudici; G Sironi; C Caslini; A Rambaldi; R Giavazzi
Journal:  Clin Exp Metastasis       Date:  1991 Sep-Oct       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.